Transfection Reagents and Equipment Market: High-Growth Opportunities in Asian Region
This report analyzes and studies the major market drivers, restraints / challenges and opportunities in the Transfection Reagents and Equipment Market.
(EMAILWIRE.COM, August 02, 2018 ) Browse 134 market data tables and 43 figures spread through 209 pages and in-depth TOC on “Transfection Reagents and Equipment Market”
https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html
Early buyers will receive 10% customization on this report.
The key factors driving the growth of this market are technology advancements in transfections, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.
On the other hand, factors such as selective effectiveness of transfection reagents, home brew reagents by researchers, and high cost of transfection reagents are expected to limit the growth of the market.
The global transfection reagents market is segmented on the basis of product, method, application, end user, and region. On the basis of product, the market is segmented into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=139141146
On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology & pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and reagents with greater efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.
Some of the prominent players in the transfection reagents market include Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands). Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=139141146
Target Audience
# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html
Early buyers will receive 10% customization on this report.
The key factors driving the growth of this market are technology advancements in transfections, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.
On the other hand, factors such as selective effectiveness of transfection reagents, home brew reagents by researchers, and high cost of transfection reagents are expected to limit the growth of the market.
The global transfection reagents market is segmented on the basis of product, method, application, end user, and region. On the basis of product, the market is segmented into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=139141146
On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology & pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and reagents with greater efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.
Some of the prominent players in the transfection reagents market include Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands). Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=139141146
Target Audience
# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Contact Information:
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results